Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2008;51:1156-1162
Published online before print February 7, 2008, doi: 10.1161/HYPERTENSIONAHA.107.105247
Free Article
This Article
Free upon publication Free Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
51/4/1156    most recent
HYPERTENSIONAHA.107.105247v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Seda, O.
Right arrow Articles by Hamet, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seda, O.
Right arrow Articles by Hamet, P.
Related Collections
Right arrow Clinical genetics
Right arrow Genetics of cardiovascular disease

(Hypertension. 2008;51:1156.)
© 2008 American Heart Association, Inc.


Go Red Original Articles

Systematic, Genome-Wide, Sex-Specific Linkage of Cardiovascular Traits in French Canadians

Ondrej Seda; Johanne Tremblay; Daniel Gaudet; Pierre-Luc Brunelle; Alexandru Gurau; Ettore Merlo; Louise Pilote; Sergei N. Orlov; Francis Boulva; Milan Petrovich; Theodore A. Kotchen; Allen W. Cowley, Jr; Pavel Hamet

From the Centre de Recherche (O.S., J.T., P-L.B., A.G., S.N.O., F.B., P.H.), Centre Hospitalier de l’Université de Montréal–Technôpole Angus, Montreal, Quebec, Canada; Complexe Hospitalier de la Sagamie (D.G.), Chicoutimi, Quebec, Canada; École Polytechnique de Montreal (E.M.), Montreal, Quebec, Canada; McGill University Health Center (L.P.), Montreal, Quebec, Canada; and the Medical College of Wisconsin (T.A.K., A.W.C.), Milwaukee, Wis.

Correspondence to Pavel Hamet, Research Centre, Centre Hospitalier de l’Université de Montréal–Technôpole Angus, 4th Floor, Room 401-F, 2901 Rachel St East, Montreal, Quebec, Canada H1W 4A4. E-mail pavel.hamet{at}umontreal.ca


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The sexual dimorphism of cardiovascular traits, as well as susceptibility to a variety of related diseases, has long been recognized, yet their sex-specific genomic determinants are largely unknown. We systematically assessed the sex-specific heritability and linkage of 539 hemodynamic, metabolic, anthropometric, and humoral traits in 120 French-Canadian families from the Saguenay-Lac-St-Jean region of Quebec, Canada. We performed multipoint linkage analysis using microsatellite markers followed by peak-wide linkage scan based on Affymetrix Human Mapping 50K Array Xba240 single nucleotide polymorphism genotypes in 3 settings, including the entire sample and then separately in men and women. Nearly one half of the traits were age and sex independent, one quarter were both age and sex dependent, and one eighth were exclusively age or sex dependent. Sex-specific phenotypes are most frequent in heart rate and blood pressure categories, whereas sex- and age-independent determinants are predominant among humoral and biochemical parameters. Twenty sex-specific loci passing multiple testing criteria were corroborated by 2-point single nucleotide polymorphism linkage. Several resting systolic blood pressure measurements showed significant genotype-by-sex interaction, eg, male-specific locus at chromosome 12 (male-female logarithm of odds difference: 4.16; interaction P=0.0002), which was undetectable in the entire population, even after adjustment for sex. Detailed interrogation of this locus revealed a 220-kb block overlapping parts of TAO-kinase 3 and SUDS3 genes. In summary, a large number of complex cardiovascular traits display significant sexual dimorphism, for which we have demonstrated genomic determinants at the haplotype level. Many of these would have been missed in a traditional, sex-adjusted setting.


Key Words: sex dimorphism • genetic linkage • single nucleotide polymorphisms • cardiovascular disease


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The sexual dimorphism of many physiological traits, as well as susceptibility to a wide variety of diseases, including hypertension, has long been recognized.1 Both social and environmental factors, as well as biological influences, contribute to this dimorphism, yet their relative relevance is not well appreciated. Contributing genetic factors have been documented in both human subjects2–4 and animal models.5–9 However, only recent investigations into the sex-specific genetic architecture of complex traits led to the hypothesis that even the determinants of common conditions like hypertension, such as humoral regulation of volume,10 and reaction to outcome events, such as myocardial infarction,11 may have both unisex and sex-specific genetic determinants.4 If that is the case, adjustment for sex during the analysis and interpretation of data may actually hide a significant portion of genome-driven physiology unique for men or women. Recent investigation found that less than one quarter of 628 recently published clinical cardiovascular studies reported sex-specific results.12 There is a potentially sizeable impact of the genetically driven, sex-specific pathophysiology on clinical management of the above-mentioned conditions. Women have been shown to be more prone to adverse effects of, eg, angiotensin-converting enzyme inhibitors or antiarrhythmic drugs,13 and the beneficial effects of aspirin therapy were reported to be attributed to reduction in the risk of ischemic stroke, but not myocardial infarction, in women, with the opposite observation in men.14

The sex-specific genetic architecture has been described for blood pressure (BP),15–20 triglycerides, high-density lipoprotein cholesterol,21 fasting insulin,22 type 2 diabetes,23 body mass index,24,25 percentage of body fat,26 bone mineral density,27 serotonin28 and cortisol29 levels, asthma,30 autism,31 stuttering,32 and several other complex phenotypes in various geoethnic groups. We previously reported the largest set of loci significantly linked to hypertension and its metabolic components in the founder population of French Canadians from the Saguenay-Lac-St-Jean region of Quebec.33,34 Because we noted that sex explained a significant portion of variation in several cardiovascular phenotypes,34 we decided to harness the wealth of gathered phenotypic data by systematic analysis of sex-specific heritability and microsatellite- and single nucleotide polymorphism (SNP)–based linkage of 539 direct and derived anthropometric, metabolic, hemodynamic, and humoral traits, which have not been reported to date.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Extended Methods and Results sections can be found in the online data supplement, available at http://hyper.ahajournals.org.

Cohort and phenotyping were described previously.34–37 Details may be found in the online data supplement. The study was approved by the ethics committees of Complexe Hospitalier de la Sagamie, Université du Québec à Chicoutimi, and the Centre Hospitalier de l’Université de Montréal. All of the subjects gave their informed consent. All of the phenotyping was performed by trained personnel who followed standard operating procedures, as described previously.34–37

Genotyping
Genotyping with microsatellite markers has been described previously.34 SNP genotypes were assessed in the Centre Hospitalier de l’Université de Montréal Research Centre, Montreal, with the GeneChip Human Mapping 50K Array Xba240 (Affymetrix).

Linear Regression
To evaluate the correlation between a trait and sex, we used a linear regression model: trait=f (age, sex), where age was an additional covariate, implemented in the GNU R statistical package, version 2.1.1. This test reports a P value and a correlation coefficient R2, which indicate the proportion of variance because of age and sex.

Estimation of Narrow-Sense Heritability
We estimated narrow-sense heritability (h2N) by a variance-components approach implemented in SOLAR, version 2.1.1. Phenotypes were first adjusted for covariates, age and sex (in the combined sample), only when appropriate. A model containing environmental and additive variance components was then created with a constraint being that they sum to 1 (h2r+e2=1) and was computed separately for each sex.

Linkage Analyses
Multipoint and 2-point linkage analyses were performed by the variance components approach implemented in SOLAR, version 2.1.1, in 3 settings, including the entire sample and then separately in men and women. The genetic information was represented by 437 microsatellite markers uniformly distributed throughout the whole genome and GeneChip Human Mapping 50K Array Xba240-derived SNPs. Age and sex were considered as covariates in linkage analyses of the combined (male+female) set. When significant (P<0.05), the covariates were retained in the final models. Sex-specific linkage was accomplished by representing the other sex phenotype data as missing.

Linkage disequilibrium analysis was performed using Haploview 4.0.38 The default algorithm of generation of linkage disequilibrium blocks was CIs, according to Gabriel et al.39


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Sex and Age Dependence of Analyzed Traits
In the first step, we performed linear regression analysis of 539 phenotypes with sex and age (Table 1). We found 47.3% phenotypes to be age and sex independent, 14.5% phenotypes to be specifically age dependent, 13.8% phenotypes to be sex dependent only, and 24.4% phenotypes to be both age and sex dependent after correction for multiple comparisons. Figure 1 illustrates the frequency of sex, age, sex and age, and independent traits in major cardiovascular-related categories. Details on each category are shown in Table S1. In the group of sex-only dependent variables, the most significant trait was the amount of body fat measured by skinfolds (P=7.2x10–108), followed by obesity-related anthropometric and body composition measures (eg, volume of extracellular water measured by bioimpedance, P=3.9x10–98) and biochemical traits (eg, hematocrit, P=5.6x10–67). Among traits with exclusive age-specific distribution, various measures of systolic BP (SBP) but not diastolic BP were most prominent, eg, SBP by ambulatory blood pressure measurement (P=2.8x10–44). Both sex and age mainly affected the variability of several body composition traits and height, followed by mostly diastolic BP measures. Because the present study is focused on sex-specific features, the analysis hereafter considers only sex-related features of the genetic architecture of the studied traits.


View this table:
[in this window]
[in a new window]

 
Table 1. Number of Phenotypes for Which Sex and/or Age Are Significant Covariates in a Linear Regression Model


Figure 1
View larger version (32K):
[in this window]
[in a new window]

 
Figure 1. Distribution of sex, age and sex, and age-related traits in major phenotype categories. Relative frequencies of phenotypes for which sex ({blacksquare}), age ({square}), and sex and age (Figure 1) are significant covariates in the linear regression model after correction for multiple testing (P<9.3x10–5). The percentage of traits in each major phenotype category not passing the threshold is indicated as independent (IND., Figure 1). BP/HR indicate cardiac indices; HUMORAL/BCH, humoral and biochemical measures.

Sex-Specific Heritability
We identified a substantial gradient along the comparison of estimates of h2N between the sexes (Figure S1). Among the traits, where single-sex h2N was higher than that of the combined sample, there were almost twice as many traits showing 20%, 40%, and 60% h2N sex difference in the male than in the female subsets. The most contrasting observations are summarized in Table 2. One-thousand permutations performed on 13 of the most contrasting phenotypes indicate that the larger heritability differences between men and women correspond on average with lower P values (Pearson correlation coefficient r=–0.57) and are, thus, more likely to represent genuine heritability differences. Nevertheless, because heritability computed by SOLAR is not robust to the addition of even a few individuals, especially in small groups, we proceeded to much more robust linear regression and linkage analysis.


View this table:
[in this window]
[in a new window]

 
Table 2. Comparison of h2N of Traits Where Single-Sex h2N Was Higher Than That of the Combined Sample and the Between-Sex Difference Was >50%

Linkage
We identified 270 loci showing >2.0 logarithm of odds (LOD) point differences between the linkage signals found in the respective sexes. Then, we performed 10 000 permutation tests, and after adjusting for multiple comparisons (P<9.3x10–5), we retrieved 31 sex-specific quantitative trait loci (QTLs) based on the microsatellite map (Table S2). Focusing on 1-LOD drop support intervals under the linkage peaks, we subsequently carried out 2-point linkage with SNPs (n=90 to 1662 SNP per QTL). On 20 occasions, we were able to confirm the presence of a sex-specific signal, depicted in Figure S2. Table 3 contains detailed information on the 10 male-specific and 10 female-specific loci. Four observations mapping to the same region of chromosome 12 pertain to related phenotypes and putatively represent 1 biological signal, reducing male-specific QTLs to 7. The supine SBP showed male-specific linkage on chromosome 12 with a single SNP exceeding LOD 4 (Figure 2A). This region belongs to the 220-kb haplotype block encompassing most of the TAO-kinase 3 gene and part of the suppressor of the defective silencing 3 homolog SUDS3 gene (Figure 2B). We then analyzed the impact of the alleles of relevant SNPs on supine SBP in both sexes. As illustrated in Figure 2C, there was a significant opposite impact on SBP of rs575121 male GG homozygotes having the highest BP (131±4 mm Hg), whereas the same allele in women resulted in the lowest BPs (113±4 mm Hg; sex*rs575121 interaction, P=0.03). Heart rate (HR) under varying physiological circumstances also displayed significant sex-specific linkage in 6 distinct loci constituting the most frequent dimorphic feature (Figure S3). The majority of identified sex-specific signals mapped to intergenic regions. Two of them resided within recently reported copy number variants (http://projects.tcag.ca/variation/): HR change during norepinephrine infusion on chromosome 11 (rs566797) and cAMP on chromosome 19 (rs10500275), both representing female-specific QTLs in our cohort (Table 3).


View this table:
[in this window]
[in a new window]

 
Table 3. Summary of Sex-Specific Linkage Signals Significant in Genome-Wide Multipoint Linkage, Using Microsatellites and Peak-Wide 2-Point Linkage With SNPs


Figure 2
View larger version (17K):
[in this window]
[in a new window]

 
Figure 2. A, Male-specific linkage of supine SBP on chromosome 12 by microsatellite-based multipoint linkage and 2-point linkage with SNPs. B, Detailed view of linkage disequilibrium at the peak of 2-point linkage is shown using Haploview 4.0-generated linkage disequilibrium blocks as described in the Methods section. The values of D' are indicated in number and by color (for LOD ≥2: bright red: D'=1, shades of red/pink: D'<1; for LOD <2: white), with indication of gene tracks in the region. C, SBP (age-adjusted mean±SE) in the supine position according to sex and genotype of rs575121. Only significant results of Tukey’s posthoc tests between women and men of identical genotypes are shown. ***P<0.001.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
The sexual dimorphism of physiological traits and even diseases is historically recognized, as well as its impact on cardiovascular outcomes (cardiovascular disease),40–42 contrasting with therapeutic guidelines, which suggest generally the same medication choices for both sexes. Over the last decade, several candidate genes for specific traits were explored for their dimorphism, such as a sex-specific impact of the tumor necrosis factor-{alpha} gene on abdominal obesity in men and the thigh region in women.2 Then, genome-wide search for sex-specific determinants of single phenotypes ensued.15–32 In 2000 subjects from the Framingham study, plasma natriuretic peptide (ANP) levels disclosed different degrees of heritability in men and women, but only suggestive linkage was found at 2 chromosomes.10 In the present study, the physiological relevance of ANP, cGMP, and urinary sodium pathway43 demonstrated a consistent heritability pattern, particularly in the standing position, in females only. For plasma renin activity, significant heritability (66%) was detected previously only in the male subgroup.44 This is in concordance with our observation of several renin measurements showing disproportionately larger heritability in men (Table 2). In 1 of the first systematic approaches to evaluating sex-specific genetic architecture of complex traits, Weiss et al4 have assessed heritability and linkage of 17 quantitative traits in Hutterites, 3 of them reaching the criteria for genome-wide significance.

Here, we report the results of sex-specific scans applied to 539 phenotypes based on our past thorough exploration of dense phenotyping in French-Canadian subjects,34 revealing 20 significant QTLs with consistent sex-specific linkage to various hemodynamic, anthropometric, humoral, and metabolic traits. If we had implemented the commonly used sex-adjustment, all of these potentially important genomic variants would have been missed.

Our most relevant results point to a region of chromosome 12, specifically to the TAOK3 gene. Indeed, this member of the mitogen-activated protein kinase cascade will deserve further exploration, because sexual dimorphism has been demonstrated in many studies of heart remodeling, including that after myocardial infarction.11 Actually, 3 other genes containing intronic SNPs significantly linked to BP and HR measures in this study have a common feature with TAOK3: they are all involved in fundamental cellular signaling pathways. Furthermore, as the homozygotes of the minor allele (GG) of the above-mentioned chromosome 12 variant rs575121 represented 16% to 25% of whites, the potential importance of the TAOK3 variation may well reach beyond the specific Saguenay-Lac-St-Jean population.

SNP rs1360005, showing significant male-specific linkage to insulin level during the glucose tolerance test, is located in the immediate vicinity of 5'-untranslated region of the SORBS1 gene. This is a member of a phosphatidylinositol 3-kinase–independent pathway for insulin-stimulated translocation of the glucose transporter GLUT4.45 Despite this positive role of SORBS1 in glucose uptake, it has been shown recently that deletion of the gene protects against high-fat diet–induced insulin resistance in mice while also having an opposite, insulin-sensitizing effect, accompanied by reduction of markers of inflammation.46 Nevertheless, no sex-dependent physiological effects were reported for SORBS1 polymorphisms so far in humans or animal models.

HR is recognized as an independent predictor of cardiac events, especially in the male sex,47 particularly at rest.48 In the present study, intronic SNP in thyroid hormone receptor-β was linked uniquely to HR in women. This observation is of interest, because thyroid hormone receptor-β is the predominant isoform in the liver, whereas T3 effects on HR are mediated mostly by thyroid hormone receptor-{alpha}.

In comparison to reported studies of sex-specific linkage, we noted several possible overlapping signals but none for the identical phenotype. The female-specific locus for sodium excretion quantity overlaps with suggestive linkage reported for fasting insulin in African-American women from the Hypertension Genetic Epidemiology Network Study.22 The male-specific locus for trunk:extremity ratio may actually overlap with male-specific suggestive serotonin level linkage in Hutterites.4 We can speculate that, within the framework of a recently proposed systemic view of complex conditions, the Human Diseasome,49 certain nodes and pathways shared among distinct common diseases may be preferentially frequented by one or the other sex.

Sex is a biological status determined by sex chromosomes and their interactions with autosomes, X-chromosome inactivation, sex hormones, and related determinants. Gender is in part determined by the above, but also submitted to sociocultural and educational shaping, eg, in some societies, fat in women is praised, whereas other geoethnic groups value slenderness. In this context, the observable traits in humans are subject to both sex and gender influences, even in the presence of a strong genetic component.50 Here, we further report its wide-range relevance, in fact, similar in extent to that of age. One of the potential limitations of this study is a possible geoethnic specificity of the findings, which requires validation in sex-specific analyses in additional cohorts. However, even concordance between human populations in the sex dependency of some phenotypes does not resolve the sex versus gender impact, because the expression of a given phenotype can indeed be modulated by sociocultural influences. A systematic search for the sex dimorphism in syntenic regions for the corresponding biological function in rodent models7,8,51 will have to be undertaken to help to distinguish between sex and gender as physiological determinants.

Perspectives
The clinical implications of the presented results are well in term with several empirical observations,52 like the Medical Research Council trial in >17 000 patients, where benefit was associated with active treatment only in men considering all-cause mortality, whereas the opposite effect was found in women.53 The results of this and other studies indicate the possibility of genetically, rather than empirically driven,13,14 sex-specific clinical management of complex conditions, a more tangible concept before the implementation of a full-blown personalized medicine based on pharmacogenomics. We conclude that a significant portion of complex cardiovascular traits displays significant sexual dimorphism, for which we have demonstrated genomic determinants at the haplotype level. These results underline the weakness of sex adjustment used in many linkage studies and underscore the need for sex-specific evaluations.


*    Acknowledgments
 
Sources of Funding

This work was supported by funds from the National Institutes of Health Specialized Center of Research HL-54998, Canadian Institutes of Health Research (Cardiogene Consortium, MT-11463 and MT-14654), and by a grant from the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada to the Gender and Sex Determinants of Cardiovascular Disease: From Bench to Beyond (GENESIS) intercapacity enhancement team on gender and sex determinants of cardiovascular diseases.

Disclosures

None.

Received November 19, 2007; first decision December 17, 2007; accepted December 31, 2007.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Safar ME, Smulyan H. Hypertension in women. Am J Hypertens. 2004; 17: 82–87.[CrossRef][Medline] [Order article via Infotrieve]
  2. Pausova Z, Deslauriers B, Gaudet D, Tremblay J, Kotchen TA, Larochelle P, Cowley AW, Hamet P. Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadians. Hypertension. 2000; 36: 14–19.[Abstract/Free Full Text]
  3. Charchar FJ, Tomaszewski M, Strahorn P, Champagne B, Dominiczak AF. Y is there a risk to being male? Trends Endocrinol Metab. 2003; 14: 163–168.[CrossRef][Medline] [Order article via Infotrieve]
  4. Weiss LA, Pan L, Abney M, Ober C. The sex-specific genetic architecture of quantitative traits in humans. Nat Genet. 2006; 38: 218–222.[CrossRef][Medline] [Order article via Infotrieve]
  5. Clark JS, Jeffs B, Davidson AO, Lee WK, Anderson NH, Bihoreau MT, Brosnan MJ, Devlin AM, Kelman AW, Lindpaintner K, Dominiczak AF. Quantitative trait loci in genetically hypertensive rats. Possible sex specificity. Hypertension. 1996; 28: 898–906.[Abstract/Free Full Text]
  6. Kloting I, Kovacs P, van den Brandt J. Sex-specific and sex-independent quantitative trait loci for facets of the metabolic syndrome in WOKW rats. Biochem Biophys Res Commun. 2001; 284: 150–156.[CrossRef][Medline] [Order article via Infotrieve]
  7. Ueno T, Tremblay J, Kunes J, Zicha J, Dobesova Z, Pausova Z, Deng AY, Sun Y, Jacob HJ, Hamet P. Gender-specific genetic determinants of blood pressure and organ weight: pharmacogenetic approach. Physiol Res. 2003; 52: 689–700.[Medline] [Order article via Infotrieve]
  8. Moreno C, Dumas P, Kaldunski ML, Tonellato PJ, Greene AS, Roman RJ, Cheng Q, Wang Z, Jacob HJ, Cowley AW Jr. Genomic map of cardiovascular phenotypes of hypertension in female Dahl S rats. Physiol Genomics. 2003; 15: 243–257.[Abstract/Free Full Text]
  9. Herrera VL, Tsikoudakis A, Ponce LR, Matsubara Y, Ruiz-Opazo N. Sex-specific QTLs and interacting loci underlie salt-sensitive hypertension and target organ complications in Dahl S/jrHS hypertensive rats. Physiol Genomics. 2006; 26: 172–179.[Abstract/Free Full Text]
  10. Wang TJ, Larson MG, Levy D, Benjamin EJ, Corey D, Leip EP, Vasan RS. Heritability and genetic linkage of plasma natriuretic peptide levels. Circulation. 2003; 108: 13–16.[Abstract/Free Full Text]
  11. Jain M, Liao R, Podesser BK, Ngoy S, Apstein CS, Eberli FR. Influence of gender on the response to hemodynamic overload after myocardial infarction. Am J Physiol Heart Circ Physiol. 2002; 283: H2544–H2550.[Abstract/Free Full Text]
  12. Blauwet LA, Hayes SN, McManus D, Redberg RF, Walsh MN. Low rate of sex-specific result reporting in cardiovascular trials. Mayo Clin Proc. 2007; 82: 166–170.[Medline] [Order article via Infotrieve]
  13. Jochmann N, Stangl K, Garbe E, Baumann G, Stangl V. Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases. Eur Heart J. 2005; 26: 1585–1595.[Abstract/Free Full Text]
  14. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA. 2006; 295: 306–313.[Abstract/Free Full Text]
  15. Franceschini N, MacCluer JW, Goring HH, Cole SA, Rose KM, Almasy L, Diego V, Laston S, Lee ET, Howard BV, Best LG, Fabsitz RR, Roman MJ, North KE. A quantitative trait loci-specific gene-by-sex interaction on systolic blood pressure among American Indians: the Strong Heart Family Study. Hypertension. 2006; 48: 266–270.[Abstract/Free Full Text]
  16. Rana BK, Insel PA, Payne SH, Abel K, Beutler E, Ziegler MG, Schork NJ, O’Connor DT. Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension. 2007; 49: 96–106.[Abstract/Free Full Text]
  17. Scurrah KJ, Byrnes GB, Hopper JL, Harrap SB. Sex differences in genetic and environmental determinants of pulse pressure. Genet Epidemiol. 2006; 30: 397–408.[CrossRef][Medline] [Order article via Infotrieve]
  18. Ellis JA, Infantino T, Harrap SB. Sex-dependent association of blood pressure with oestrogen receptor genes ERalpha and ERbeta. J Hypertens. 2004; 22: 1127–1131.[CrossRef][Medline] [Order article via Infotrieve]
  19. McArdle PF, Dytch H, O’connell JR, Shuldiner AR, Mitchell BD, Abney M. Homozygosity by descent mapping of blood pressure in the Old Order Amish: evidence for sex specific genetic architecture. BMC Genet. 2007; 8: 66.[CrossRef][Medline] [Order article via Infotrieve]
  20. Glorioso N, Herrera VL, Bagamasbad P, Filigheddu F, Troffa C, Argiolas G, Bulla E, Decano JL, Ruiz-Opazo N. Association of ATP1A1 and dear single-nucleotide polymorphism haplotypes with essential hypertension: sex–specific and haplotype-specific effects. Circ Res. 2007; 100: 1522–1529.[Abstract/Free Full Text]
  21. Mosher MJ, Martin LJ, Cupples LA, Yang Q, Dyer TD, Williams JT, North KE. Genotype-by-sex interaction in the regulation of high-density lipoprotein: the Framingham Heart Study. Hum Biol. 2005; 77: 773–793.[CrossRef][Medline] [Order article via Infotrieve]
  22. North KE, Franceschini N, Borecki IB, Gu CC, Heiss G, Province MA, Arnett DK, Lewis CE, Miller MB, Myers RH, Hunt SC, Freedman BI. Genotype-by-sex interaction on fasting insulin concentration: the HyperGEN study. Diabetes. 2007; 56: 137–142.[Medline] [Order article via Infotrieve]
  23. Avery CL, Freedman BI, Kraja AT, Borecki IB, Miller MB, Pankow JS, Arnett D, Lewis CE, Myers RH, Hunt SC, North KE. Genotype-by-sex interaction in the aetiology of type 2 diabetes mellitus: support for sex-specific quantitative trait loci in Hypertension Genetic Epidemiology Network participants. Diabetologia. 2006; 49: 2329–2336.[CrossRef][Medline] [Order article via Infotrieve]
  24. Atwood LD, Heard-Costa NL, Fox CS, Jaquish CE, Cupples LA. Sex and age specific effects of chromosomal regions linked to body mass index in the Framingham Study. BMC Genet. 2006; 7: 7.[CrossRef][Medline] [Order article via Infotrieve]
  25. Korner A, Ma L, Franks PW, Kiess W, Baier LJ, Stumvoll M, Kovacs P. Sex-specific effect of the Val1483Ile polymorphism in the fatty acid synthase gene (FAS) on body mass index and lipid profile in Caucasian children. Int J Obes (Lond). 2007; 31: 353–358.[CrossRef][Medline] [Order article via Infotrieve]
  26. Lewis CE, North KE, Arnett D, Borecki IB, Coon H, Ellison RC, Hunt SC, Oberman A, Rich SS, Province MA, Miller MB. Sex-specific findings from a genome-wide linkage analysis of human fatness in non-Hispanic whites and African Americans: the HyperGEN study. Int J Obes (Lond). 2005; 29: 639–649.[CrossRef][Medline] [Order article via Infotrieve]
  27. Ioannidis JP, Ng MY, Sham PC, Zintzaras E, Lewis CM, Deng HW, Econs MJ, Karasik D, Devoto M, Kammerer CM, Spector T, Andrew T, Cupples LA, Duncan EL, Foroud T, Kiel DP, Koller D, Langdahl B, Mitchell BD, Peacock M, Recker R, Shen H, Sol-Church K, Spotila LD, Uitterlinden AG, Wilson SG, Kung AW, Ralston SH. Meta-analysis of genome-wide scans provides evidence for sex- and site-specific regulation of bone mass. J Bone Miner Res. 2007; 22: 173–183.[CrossRef][Medline] [Order article via Infotrieve]
  28. Weiss LA, Abney M, Cook EH Jr, Ober C. Sex-specific genetic architecture of whole blood serotonin levels. Am J Hum Genet. 2005; 76: 33–41.[CrossRef][Medline] [Order article via Infotrieve]
  29. Kurina LM, Weiss LA, Graves SW, Parry R, Williams GH, Abney M, Ober C. Sex differences in the genetic basis of morning serum cortisol levels: genome-wide screen identifies two novel loci specific to women. J Clin Endocrinol Metab. 2005; 90: 4747–4752.[Abstract/Free Full Text]
  30. Ober C, Pan L, Phillips N, Parry R, Kurina LM. Sex-specific genetic architecture of asthma-associated quantitative trait loci in a founder population. Curr Allergy Asthma Rep. 2006; 6: 241–246.[CrossRef][Medline] [Order article via Infotrieve]
  31. Stone JL, Merriman B, Cantor RM, Yonan AL, Gilliam TC, Geschwind DH, Nelson SF. Evidence for sex-specific risk alleles in autism spectrum disorder. Am J Hum Genet. 2004; 75: 1117–1123.[CrossRef][Medline] [Order article via Infotrieve]
  32. Suresh R, Ambrose N, Roe C, Pluzhnikov A, Wittke-Thompson JK, Ng MC, Wu X, Cook EH, Lundstrom C, Garsten M, Ezrati R, Yairi E, Cox NJ. New complexities in the genetics of stuttering: significant sex-specific linkage signals. Am J Hum Genet. 2006; 78: 554–563.[CrossRef][Medline] [Order article via Infotrieve]
  33. Cowley AW Jr. The genetic dissection of essential hypertension. Nat Rev Genet. 2006; 7: 829–840.[Medline] [Order article via Infotrieve]
  34. Hamet P, Merlo E, Seda O, Broeckel U, Tremblay J, Kaldunski M, Gaudet D, Bouchard G, Deslauriers B, Gagnon F, Antoniol G, Pausova Z, Labuda M, Jomphe M, Gossard F, Tremblay G, Kirova R, Tonellato P, Orlov SN, Pintos J, Platko J, Hudson TJ, Rioux JD, Kotchen TA, Cowley AW Jr. Quantitative founder-effect analysis of French Canadian families identifies specific loci contributing to metabolic phenotypes of hypertension. Am J Hum Genet. 2005; 76: 815–832.[CrossRef][Medline] [Order article via Infotrieve]
  35. Pausova Z, Gaudet D, Gossard F, Bernard M, Kaldunski ML, Jomphe M, Tremblay J, Hudson TJ, Bouchard G, Kotchen TA, Cowley AW, Hamet P. Genome-wide scan for linkage to obesity-associated hypertension in French Canadians. Hypertension. 2005; 46: 1280–1285.[Abstract/Free Full Text]
  36. Kotchen TA, Broeckel U, Grim CE, Hamet P, Jacob H, Kaldunski ML, Kotchen JM, Schork NJ, Tonellato PJ, Cowley AW Jr. Identification of hypertension-related QTLs in African Am sib pairs. Hypertension. 2002; 40: 634–639.[Abstract/Free Full Text]
  37. Orlov SN, Pausova Z, Gossard F, Gaudet D, Tremblay J, Kotchen T, Cowley A, Larochelle P, Hamet P. Sibling resemblance of erythrocyte ion transporters in French-Canadian sibling-pairs affected with essential hypertension. J Hypertens. 1999; 17: 1859–1865.[CrossRef][Medline] [Order article via Infotrieve]
  38. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005; 21: 263–265.[Abstract/Free Full Text]
  39. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. The structure of haplotype blocks in the human genome. Science. 2002; 296: 2225–2229.[Abstract/Free Full Text]
  40. Oparil S, Arthur C. Corcoran Memorial Lecture. Hormones and vasoprotection. Hypertension. 1999; 33: 170–176.[Abstract/Free Full Text]
  41. Dasgupta K, O’Loughlin J, Chen S, Karp I, Paradis G, Tremblay J, Hamet P, Pilote L. Emergence of sex differences in prevalence of high systolic blood pressure: analysis of a longitudinal adolescent cohort. Circulation. 2006; 114: 2663–2670.[Abstract/Free Full Text]
  42. Joffres MR, Hamet P, MacLean DR, L’Italien GJ, Fodor G. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens. 2001; 14: 1099–1105.[CrossRef][Medline] [Order article via Infotrieve]
  43. Tremblay J, Desjardins R, Hum D, Gutkowska J, Hamet P. Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases. Mol Cell Biochem. 2002; 230: 31–47.[CrossRef][Medline] [Order article via Infotrieve]
  44. Vinck WJ, Fagard RH, Vlietinck R, Lijnen P. Heritability of plasma renin activity and plasma concentration of angiotensinogen and angiotensin-converting enzyme. J Hum Hypertens. 2002; 16: 417–422.[CrossRef][Medline] [Order article via Infotrieve]
  45. Lin WH, Huang CJ, Liu MW, Chang HM, Chen YJ, Tai TY, Chuang LM. Cloning, mapping, and characterization of the human sorbin and SH3 domain containing 1 (SORBS1) gene: a protein associated with c-Abl during insulin signaling in the hepatoma cell line Hep3B. Genomics. 2001; 74: 12–20.[CrossRef][Medline] [Order article via Infotrieve]
  46. Lesniewski LA, Hosch SE, Neels JG, de Luca C, Pashmforoush M, Lumeng CN, Chiang SH, Scadeng M, Saltiel AR, Olefsky JM. Bone marrow-specific Cap gene deletion protects against high-fat diet-induced insulin resistance. Nat Med. 2007; 13: 455–462.[CrossRef][Medline] [Order article via Infotrieve]
  47. Biagini E, Elhendy A, Bax JJ, Rizzello V, Schinkel AF, van Domburg RT, Kertai MD, Krenning BJ, Bountioukos M, Rapezzi C, Branzi A, Simoons ML, Poldermans D. Seven-year follow-up after dobutamine stress echocardiography: impact of gender on prognosis. J Am Coll Cardiol. 2005; 45: 93–97.[Abstract/Free Full Text]
  48. Jouven X, Zureik M, Desnos M, Guerot C, Ducimetiere P. Resting heart rate as a predictive risk factor for sudden death in middle-aged men. Cardiovasc Res. 2001; 50: 373–378.[Abstract/Free Full Text]
  49. Loscalzo J, Kohane I, Barabasi AL. Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol Syst Biol. 2007; 3: 124.[Medline] [Order article via Infotrieve]
  50. Pilote L, Dasgupta K, Guru V, Humphries KH, McGrath J, Norris C, Rabi D, Tremblay J, Alamian A, Barnett T, Cox J, Ghali WA, Grace S, Hamet P, Ho T, Kirkland S, Lambert M, Libersan D, O’Loughlin J, Paradis G, Petrovich M, Tagalakis V. A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ. 2007; 176: S1–S44.[Abstract/Free Full Text]
  51. Stoll M, Cowley AW Jr, Tonellato PJ, Greene AS, Kaldunski ML, Roman RJ, Dumas P, Schork NJ, Wang Z, Jacob HJ. A genomic-systems biology map for cardiovascular function. Science. 2001; 294: 1723–1726.[Abstract/Free Full Text]
  52. Bella JN, Palmieri V, Wachtell K, Liu JE, Gerdts E, Nieminen MS, Koren MJ, Zabalgoitia M, Wright JT, Dahlöf B, Devereux RB. Sex-related difference in regression of left ventricular hypertrophy with antihypertensive treatment: the LIFE study. J Hum Hypertens. 2004; 18: 411–416.[CrossRef][Medline] [Order article via Infotrieve]
  53. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ (Clin Res Ed). 1985; 291: 97–104.[Medline] [Order article via Infotrieve]




This Article
Free upon publication Free Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
51/4/1156    most recent
HYPERTENSIONAHA.107.105247v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Seda, O.
Right arrow Articles by Hamet, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seda, O.
Right arrow Articles by Hamet, P.
Related Collections
Right arrow Clinical genetics
Right arrow Genetics of cardiovascular disease